Abstract
Telemedicine applications, i.e. the use of telecommunication technologies to deliver health services over a distance, have demonstrated dramatic growth over the past decade. Reimbursement has emerged as a crucial issue as projects attempt to evolve from the demonstration stage to a mainstream component of health delivery. Payors around the world, both public and private, are currently evaluating telemedicine and making funding decisions. As summarized in this article, conclusive evidence regarding the clinical and/or cost effectiveness of telemedicine does not support generalizations regarding outcomes for telemedicine. However, further discussion in this paper demonstrates that this may not preclude payors from deciding to reimburse for services delivered via these technologies. Research from the US and the UK points to other significant historical contributors toward payor reimbursement decisions, such as consumer and market demand and payor mission.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
